Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

BMY 60.72 +1.09 (1.83%)
price chart
BTIM Corp. Reduces Position in Bristol-Myers Squibb Co (BMY)
Bristol-Myers Squibb logo BTIM Corp. decreased its position in shares of Bristol-Myers Squibb Co (NYSE:BMY) by 4.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC).
Traders Sell Bristol-Myers Squibb Co (BMY) on Strength Following Analyst ...  Intercooler Financial
Bristol-Myers Squibb Company (NYSE:BMY) Had Its PT Decreased by 7.25% at ...  WallStreet.org
Bristol-Myers Squibb Co (BMY) Lowered to Hold at TheStreet
Bristol-Myers Squibb Co logo TheStreet downgraded shares of Bristol-Myers Squibb Co (NYSE:BMY) to a hold rating in a research report released on Monday, MarketBeat.
Bristol-Myers Squibb Co (BMY) Shares Sold by AT Bancorp  Zolmax
Bristol-Myers Squibb Co. (BMY) Falls 3.21% for February 02  Equities.com
U.S. FDA Approves Expanded Use of Bristol-Myers Squibb's Daklinza (daclatasvir ...
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that Daklinza™ (daclatasvir, 60 mg), an NS5A replication complex inhibitor, has been approved by the U.S.
FDA approves expanded label of Daklinza for additional HCV patients  Healio
Bristol-Myers Squibb Co (BMY) Given New $69.00 Price Target at Sanford C ...
Bristol-Myers Squibb Co logo Bristol-Myers Squibb Co (NYSE:BMY) had its target price hosited by Sanford C. Bernstein from $67.00 to $69.00 in a research report report published on Friday morning, StockTargetPrices.
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's Unusual ...  TheStreet.com
Bristol-Myers Squibb Co (BMY) Issues FY16 Earnings Guidance  Zolmax
UPDATE: Berenberg Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
Berenberg upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Hold to Buy with a price target of $77. Analyst Laura Sutcliffe said Bristol-Myers is in a very good place to deliver strong growth in the medium term.
BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform
BMO Capital downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Market Perform with a price target of $70.00 (from $74.00), saying the risk/reward is balanced here.
BMO Downgrades Whole Foods And Bristol-Myers Squibb To Start Week: Why?
Whole Foods Market, Inc. (NASDAQ: WFM) shares have lost 12 percent since December 28, while shares of Bristol-Myers Squibb Co (NYSE: BMY) are down 7 percent. BMO Capital Markets analysts downgraded the ratings and reduced the price targets of ...
Charter Trust Company Has $3222000 Position in Bristol-Myers Squibb Co (BMY)  EMQ
Bristol-Myers Squibb Co (BMY) Stake Raised by Atalanta Sosnoff Capital  Zolmax
Bristol-Myers Squibb Company (NYSE:BMY) Secures A Place In Top Stocks
The analysts covering Bristol-Myers Squibb Company (NYSE:BMY) have assigned its stock a price target of $73.90, which reflects the market consensus of market experts polled by Thomson Reuters.
P. R. Herzig & Company Increases Stake in Bristol-Myers Squibb Co (BMY)
Bristol-Myers Squibb logo P. R. Herzig & Company raised its stake in Bristol-Myers Squibb Co (NYSE:BMY) by 0.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC).
Bristol-Myers Squibb Co. (BMY) is Trading Lower on Unusual Volume for January 18  Equities.com
Agree To Buy Bristol-Myers Squibb At $35, Earn 4.4% Using Options  Forbes
Bristol-Myers Squibb Co (BMY) Stake Boosted by Cadence Bank NA
Bristol-Myers Squibb logo Cadence Bank NA boosted its position in Bristol-Myers Squibb Co (NYSE:BMY) by 0.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.